Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-11-001838
Filing Date
2011-01-07
Accepted
2011-01-07 12:51:18
Documents
1
Period of Report
2011-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 42038
  Complete submission text file 0001140361-11-001838.txt   43890
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address
CAVAZZA PAOLO (Reporting) CIK: 0001163608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 11516598